Genomes and Genes


Jen Jen Yeh


Affiliation: University of North Carolina
Country: USA


  1. Yeh J. Prognostic signature for pancreatic cancer: are we close?. Future Oncol. 2009;5:313-21 pubmed publisher
    ..This review will therefore focus on the advantages of a prognostic gene signature for pancreatic cancer, the advances that have been made thus far, the approaches used and the challenges that remain...
  2. Lipner M, Yeh J. Sequencing Pancreatic Juice: Squeezing the Most Out of Surveillance. Clin Cancer Res. 2018;24:2713-2715 pubmed publisher
    ..Future studies are needed to optimize this approach and determine how it best fits into clinical practice. Clin Cancer Res; 24(12); 2713-5. ©2018 AACRSee related article by Suenaga et al., p. 2963. ..
  3. Neel N, Stratford J, Shinde V, Ecsedy J, Martin T, Der C, et al. Response to MLN8237 in pancreatic cancer is not dependent on RalA phosphorylation. Mol Cancer Ther. 2014;13:122-33 pubmed publisher
    ..Ki67 may be an effective pharmacodynamic biomarker to identify response early in the course of treatment. ..